Spero Therapeutics is trading 5.26% higher at $1.20 in pre-market on October 9, 2026; the reason for the move remains unclear. - The latest located company announcement was October 2, about employee inducement grants, not a new October 9 development. - Broader pre-market indices are mixed-to-positive, but available evidence does not establish that market sentiment drove the move.